| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
PRAX
Praxis Precision Medicines
|
Aug 07, 2026 | BUY |
Strong Buy
+49.7% avg upside
24 analysts
|
$514.00
42.40% Upside
|
+0.0% | · |
|
MIRM
Mirum Pharmaceuticals
|
Aug 06, 2026 | BUY |
Strong Buy
+13.0% avg upside
22 analysts
|
$123.00
22.31% Upside
|
+4.9% | · |
|
AMGN
Amgen
|
Aug 05, 2026 | SELL |
Buy
-23.3% avg upside
57 analysts
|
$230.00
44.11% Downside
|
-2.3% | · |
|
JAZZ
Jazz Pharmaceuticals
|
Aug 04, 2026 | BUY |
Strong Buy
-8.0% avg upside
35 analysts
|
$280.00
9.08% Upside
|
-1.9% | · |
|
NBIX
Neurocrine
|
Jul 31, 2026 | BUY |
Strong Buy
+14.9% avg upside
37 analysts
|
$225.00
37.74% Upside
|
-2.0% | · |
|
REGN
Regeneron
|
Jul 31, 2026 | HOLD |
Strong Buy
-0.6% avg upside
58 analysts
|
$761.00
2.92% Downside
|
+2.9% | · |
|
VRTX
Vertex Pharmaceuticals
|
Jul 07, 2026 | SELL |
Strong Buy
-12.0% avg upside
62 analysts
|
$350.00
29.41% Downside
|
+5.0% | · |
|
RGNX
RegenXBio
|
Jun 23, 2026 | BUY |
Strong Buy
+254.0% avg upside
22 analysts
|
$32.00
198.45% Upside
|
+7.7% | · |
|
ANRO
Alto Neuroscience, Inc.
|
May 18, 2026 | BUY |
Strong Buy
+6.5% avg upside
13 analysts
|
$36.00
25.59% Upside
|
+31.5% | · |
|
AXSM
Axsome Therapeutics
|
May 05, 2026 | BUY |
Strong Buy
+8.9% avg upside
29 analysts
|
$246.00
15.59% Upside
|
-1.0% | · |
|
XENE
Xenon
|
Mar 09, 2026 | BUY |
Strong Buy
-1.8% avg upside
28 analysts
|
$97.00
53.10% Upside
|
+1.0% | · |
|
SRPT
Sarepta Therapeutics
|
Feb 26, 2026 | HOLD |
Buy
+255.8% avg upside
49 analysts
|
$20.00
19.15% Upside
|
-3.8% | · |
|
GILD
Gilead Sciences
|
Feb 11, 2026 | HOLD |
Strong Buy
-10.8% avg upside
66 analysts
|
$145.00
8.83% Upside
|
-13.6% | · |
|
BIIB
Biogen
|
Oct 31, 2025 | BUY |
Strong Buy
+21.6% avg upside
52 analysts
|
$250.00
20.28% Upside
|
+34.8% | · |
|
CRNX
Crinetics Pharmaceuticals
|
Sep 26, 2025 | BUY |
Buy
-7.9% avg upside
21 analysts
|
$62.00
26.23% Downside
|
+82.8% | · |
|
BHVN
Biohaven Ltd.
|
Aug 12, 2025 | BUY |
Buy
+55.9% avg upside
25 analysts
|
$52.00
254.77% Upside
|
+7.9% | · |
|
DYN
Dyne Therapeutics
|
Jun 18, 2025 | BUY |
Strong Buy
+51.7% avg upside
31 analysts
|
$32.00
21.87% Upside
|
+83.7% | · |
|
ALMS
Alumis Inc.
|
Feb 07, 2025 | BUY |
Strong Buy
+38.8% avg upside
11 analysts
|
$17.00
38.49% Downside
|
+361.9% | · |
|
BNTC
Benitec Biopharma
|
Dec 12, 2024 | BUY |
Strong Buy
+83.7% avg upside
14 analysts
|
$30.00
120.13% Upside
|
-3.0% | · |
|
ENTA
Enanta Pharmaceuticals
|
Nov 26, 2024 | BUY |
Buy
+138.3% avg upside
17 analysts
|
$20.00
45.25% Upside
|
+62.8% | · |
|
LXEO
Lexeo Therapeutics, Inc.
|
Nov 20, 2024 | BUY |
Strong Buy
+306.5% avg upside
11 analysts
|
$28.00
482.03% Upside
|
+45.6% | · |
|
ABUS
Arbutus Biopharma
|
Nov 06, 2024 | HOLD |
Strong Buy
+91.6% avg upside
15 analysts
|
$4.00
13.60% Downside
|
+13.3% | · |
|
NRIX
Nurix Therapeutics
|
Sep 05, 2024 | BUY |
Strong Buy
+26.0% avg upside
28 analysts
|
$26.00
1.77% Upside
|
-59.5% | · |
|
OKUR
OnKure Therapeutics
|
Dec 14, 2023 | HOLD |
Buy
+474.2% avg upside
13 analysts
|
$30.00
624.59% Upside
|
-26.4% | · |
|
CUE
Cue Biopharma
|
Nov 10, 2022 | BUY |
Strong Buy
-65.1% avg upside
9 analysts
|
$28.00
3.34% Upside
|
-26.0% | · |
|
VTGN
VistaGen Therapeutics
|
Nov 10, 2022 | HOLD |
Hold
+801.4% avg upside
8 analysts
|
$7.50
2507.71% Upside
|
-34.1% | · |
|
TBPH
Theravance Biopharma
|
Nov 07, 2022 | HOLD |
Buy
+9.0% avg upside
18 analysts
|
$8.00
52.78% Downside
|
-3.2% | · |
|
IMVT
Immunovant
|
Sep 08, 2022 | HOLD |
Strong Buy
-1.7% avg upside
24 analysts
|
$6.00
85.08% Downside
|
+359.1% | · |
|
ASMB
Assembly Biosciences
|
Mar 31, 2022 | BUY |
Strong Buy
+27.2% avg upside
10 analysts
|
$15.00
43.77% Downside
|
-59.2% | · |
|
TIL
Instil Bio
|
Aug 12, 2021 | BUY |
Buy
+352.1% avg upside
8 analysts
|
$34.00
358.89% Upside
|
· | · |
|
QTTB
Q32 Bio
|
Aug 12, 2021 | BUY |
Buy
+282.2% avg upside
24 analysts
|
$16.00
2.61% Upside
|
-59.7% | · |
|
CLLS
Cellectis SA
|
Aug 06, 2021 | BUY |
Strong Buy
+609.5% avg upside
16 analysts
|
$39.00
1275.59% Upside
|
-75.8% | · |
|
NTLA
Intellia Therapeutics
|
Aug 05, 2021 | HOLD |
Buy
+223.1% avg upside
37 analysts
|
$146.00
1122.76% Upside
|
-61.7% | · |
|
VYGR
Voyager Therapeutics
|
May 10, 2021 | HOLD |
Strong Buy
+336.6% avg upside
23 analysts
|
$6.00
83.52% Upside
|
+47.2% | · |
|
CRIS
Curis
|
Nov 01, 2018 | BUY |
Strong Buy
+229.2% avg upside
12 analysts
|
$3.00
25.37% Downside
|
· | · |
|
ANAB
AnaptysBio
|
Mar 27, 2018 | BUY |
Strong Buy
+28.2% avg upside
26 analysts
|
$144.00
154.31% Upside
|
-37.4% | · |
|
ONC
BeOne Medicines
|
Feb 28, 2018 | HOLD |
Strong Buy
+2.4% avg upside
28 analysts
|
$138.00
60.44% Downside
|
-4.5% | · |
|
INSM
Insmed
|
Jan 04, 2018 | BUY |
Strong Buy
+33.8% avg upside
37 analysts
|
$42.00
67.99% Downside
|
-51.2% | · |
|
BMRN
BioMarin Pharmaceutical
|
Oct 03, 2017 | BUY |
Strong Buy
+47.1% avg upside
52 analysts
|
$115.00
80.18% Upside
|
+6.9% | · |
|
INVA
Innoviva
|
Jul 26, 2017 | HOLD |
Buy
+40.1% avg upside
12 analysts
|
$13.00
36.70% Downside
|
+4.7% | · |
|
NERV
Minerva Neurosciences
|
Jan 22, 2015 | BUY |
Buy
+75.2% avg upside
8 analysts
|
$11.00
157.69% Upside
|
+3.7% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.